Skip to main content

Intuitive Surgical (ISRG) Stock Price & Market Analysis

ISRG · NASDAQ · Medical Instruments & Supplies

Market closedLatest regular-session print

$414.79

▲ +$9.61(+2.37%)4:00 PM ET - vs previous close

Quote as of Sep 28, 2026, 4:00 PM EDT

NASDAQ market is closed. Showing the latest available regular-session trade from Sep 28, 2026, 4:00 PM EDT.

Yahoo Finance · latest regular-session print · as of Sep 28, 2026, 4:00 PM EDT · delay not stated · current source

Last session88%
$402.75L Sep 28 '26$416.51H Sep 28 '26
52-week31%
$328.57L Jul 23 '26$603.88H Jan 7 '26
Long-term rangesSince first print
Since first print(2000-09-28)67%
$0.6667L Apr 3 '01$616.00H Jan 23 '25

Loading price chart…

Session market context

ISRGStock · vs previous close
↑ +2.37%
QQQNasdaq-100 ETF
↓ -1.07%

ISRG outperformed the sector by 3.44 percentage points.

Price comparisons describe market context; they do not establish the cause of a move.

Data freshness

PriceAt closeLast traded

Fundamentalsevery 1 hrProvider checked

Analystevery 12 hrProvider checked

NewsTECHi refresh every 15 minLatest item

Loading upcoming events…

Reported fundamentals

ISRG research snapshot

Annual revenue

USD 10.06B

Sales reported for this fiscal year.

Revenue change

+20.5%

Compared with the prior fiscal year.

Net profit margin

28.4%

Reported net income divided by revenue.

These reported results describe the business’s recent scale and profitability. Compare cash generation and valuation before forming an investment view; historical growth is not a forecast.

Company · Profile

About Intuitive Surgical (ISRG)

Sector, leadership, and how Intuitive Surgical earns its revenue.

Intuitive Surgical

NASDAQ · ISRG · US

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Headquarters
Sunnyvale, CA, United States
Country
US
Founded
2000
Employees
17,021
CEO
Mr. David J. RosaCompany leadership source
Exchange
NASDAQ
Business model & operating evidence

Company website ↗

AI business exposure

Revenue exposure
AI-specific revenue is not separated in the available company statements.
Capital-spending dependency
No reviewed quantitative dependency model is available.
Compute role
See the sourced business description; AI labels do not establish compute revenue.
Platform examples
An exhaustive, consistently defined product inventory is unavailable.
Ecosystem links
Supplier and customer links require reviewed disclosures.

Narrative versus numbers

Demand is expanding

Supporting observation: 18.5%

Quarterly revenue growth year over year; company-wide, not exclusively AI. · TECHi unified data · 2026-06-30

Growth produces accounting profit

Supporting observation: 28.4%

Net margin. A positive figure supports profitability, not necessarily cash generation. · SEC Companyfacts · 2026-09-29T09:19:37.671Z

The business generates cash after investment

Supporting observation: 948.4M

Latest available free cash flow; period-specific, not a forecast. · SEC Companyfacts · 2026-06-30

These are explicit tests of individual claims, not an overall bull/bear rating. Demand growth can coexist with valuation, concentration and financing risk.

Operating measures

Revenue
$2.89Bquarter ended Jun 30, 2026
Gross margin
67.8%quarter ended Jun 30, 2026
Operating margin
33.6%quarter ended Jun 30, 2026
EPS
$2.29quarter ended Jun 30, 2026
Capital expenditure
$112.60Mquarter ended Jun 30, 2026
Free cash flow
$948.40Mquarter ended Jun 30, 2026
Free cash flow margin
32.8%quarter ended Jun 30, 2026
Operating cash / net income
1.30×quarter ended Jun 30, 2026
Revenue growth year over year
18.5%quarter ended Jun 30, 2026

Leadership

CEO: Mr. David J. Rosa

Source: Yahoo Finance · 2026-09-29T10:18:13.293Z

Ownership filings and insider activity
Competitors & comparisons

Loading competitor research…

Loading fund exposure…

Governance & sustainability

Dated environmental and governance disclosures are not available in this dataset. TECHi does not infer an ESG rating from profitability, volatility, headcount or executive biographies.

Find proxy statements and annual reports

Read ISRG news & coverage
All data sources

Search the dated figures used for this view. Each entry identifies its units, reporting period and calculation status.

Browse all companies and funds
Research tools
US market hours

Regular hours: 9:30 AM–4:00 PM America/New_York

Next open: Checking…

Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.